MAOB and Parkinson disease: Selegilin (SEL), an irreversible monoamine oxidase-B (MAO-B) inhibitor used to help control the symptoms of Parkinson's disease, served as a positive control reagent at an effective concentration of 10 μM (Riederer and Laux, 2011).